Corrigendum: SARS-CoV-2 seroprevalence in pregnant women in Kilifi, Kenya from March 2020 to March 2022

Front Public Health. 2024 Oct 14:12:1500467. doi: 10.3389/fpubh.2024.1500467. eCollection 2024.

Angela Koech^#^{1

2}, Geoffrey Omuse^#³, Alex G Mugo¹, Isaac G Mwaniki¹, Joseph M Mutunga¹, Moses W Mukhanya¹, Onesmus Wanje¹, Grace M Mwashigadi¹, Geoffrey G Katana⁴, Rachel Craik⁵, Peter von Dadelszen^{5

6}, Kirsty Le Doare⁷, Marleen Temmerman^{1

2

6}; periCOVID-Africa; PRECISE Network

¹ Centre of Excellence in Women and Child Health, Aga Khan University, Nairobi, Kenya.
² Department of Obstetrics and Gynaecology, Aga Khan University, Nairobi, Kenya.
³ Department of Pathology, Aga Khan University, Nairobi, Kenya.
⁴ Kilifi County Department of Health and Sanitation Services, Kilifi, Kenya.
⁵ Department of Women and Children's Health, Kings College London, London, United Kingdom.
⁶ Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
⁷ St. George's University of London, London, United Kingdom.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.3389/fpubh.2023.1292932.].

Keywords: COVID-19; Kenya; SARS-CoV-2; antibodies; pregnancy; seroprevalence.